Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
113 hedge funds and large institutions have $374M invested in Surmodics in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 39 reducing their positions, and 16 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 39
2.31% less ownership
Funds ownership: 91.83% → 89.52% (-2.3%)
3% less funds holding
Funds holding: 117 → 113 (-4)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
21% less capital invested
Capital invested by funds: $475M → $374M (-$101M)
96% less call options, than puts
Call options by funds: $6K | Put options by funds: $138K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.21M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.6M |
| 3 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$1.41M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.38M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$12.4M |
| 2 |
Millennium Management
New York
|
-$2.82M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.16M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$1.48M |
| 5 |
BlackRock
New York
|
-$903K |
SRDX Hedge Fund Activity: Q1 2024 in Review
113 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2024, worth a combined $374M — down 21% from $475M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of SRDX and 13 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 36 added.
The largest buyer was Bank of America, adding an estimated $2.21M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.
- 113 institutional investors held Surmodics (SRDX) as of Q1 2024, down from 117 in Q4 2023.
- Funds reported $374M of Surmodics stock for Q1 2024, down 21% quarter-over-quarter.
- 13 funds opened new Surmodics positions in Q1 2024 and 16 closed out, a net change of -3 holders.
- The largest Surmodics buyer in Q1 2024 was Bank of America, an estimated $2.21M added.
- The largest Surmodics seller in Q1 2024 was Morgan Stanley, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2024.